Neuright has developed a microneedle-based diagnostic device, Diagnosing Early Neuropathy (DEN), that quantitatively assesses nerve function in skin and subdermal tissues to identify small fiber peripheral neuropathy. This portable and easy-to-use platform enables clinicians to deliver rapid, accurate diagnostics in just 5 to 10 minutes, facilitating timely treatment for millions affected by this condition.
Funding
$230K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Small fiber peripheral neuropathy is a widespread condition that is often diagnosed late due to the limitations of current diagnostic methods. Existing techniques can be invasive, time-consuming, and require specialized equipment and expertise, hindering early detection and timely intervention. This results in delayed treatment and poorer outcomes for affected individuals.
Solution
Neuright has developed Diagnosing Early Neuropathy (DEN), a microneedle-based diagnostic device designed for the early and accurate detection of small fiber peripheral neuropathy. The portable, wireless device quantitatively assesses nerve function in skin and subdermal tissues, providing clinicians with objective data on nerve health. The platform enables rapid diagnostics, delivering results in 5 to 10 minutes without the need for specialized training or equipment. By facilitating early diagnosis, DEN aims to improve treatment outcomes and quality of life for individuals suffering from peripheral neuropathy.
Target Audience
The primary target audience includes clinicians, neurologists, and primary care physicians who diagnose and manage patients with peripheral neuropathy, as well as researchers studying nerve function and regeneration.
Features
- Microneedle-based technology for minimally invasive nerve function assessment
- Quantitative measurement of nerve activity in skin and subdermal tissues
- Portable and wireless design for point-of-care diagnostics
- Rapid results in 5 to 10 minutes
- User-friendly interface requiring no specialized training
- Objective data to aid in accurate diagnosis and treatment monitoring